Learn / Clinical Research Management / Safety in clinical trials
Adverse events and serious adverse events
13 minute read · 6-question quiz
What you will learn
Define adverse event, adverse reaction and serious adverse event
Grade severity and assess causality and expectedness
Record adverse events completely and consistently
Safety reporting is central to GCP. Participants must be told about risks, and the trial must detect and respond to harm quickly.
Definitions
- Adverse event (AE): any untoward medical occurrence in a participant given a product, whether or not it is related to the product. It can be a sign, symptom, abnormal laboratory result or disease.
- Adverse drug reaction (ADR): an AE for which a causal relationship with the product is at least a reasonable possibility.
- Serious adverse event (SAE): any AE that
- results in death,
- is life-threatening,
- requires hospitalisation or prolongs existing hospitalisation,
- results in persistent or significant disability or incapacity,
- is a congenital anomaly or birth defect, or
- is another medically important event.
- Suspected unexpected serious adverse reaction (SUSAR): a serious reaction suspected to be related to the product and not listed as an expected effect in the reference safety information, such as the investigator's brochure.
Serious is not the same as severe
Severity describes the intensity of an event (mild, moderate, severe). Seriousness is defined by outcome or the criteria above. A severe headache can be non-serious; a mild-seeming condition requiring hospital admission is serious.
Assessing causality
The investigator judges whether the product may have caused the event, considering:
- Timing: did it begin after the product was given, and does it fit the expected time pattern?
- Dechallenge and rechallenge: did it improve when the product stopped, and recur if restarted?
- Biological plausibility and known effects of the product class.
- Alternative explanations: disease, other drugs, infections.
Categories commonly used are not related, unlikely, possible, probable, definite. When uncertain, a more cautious assessment is preferred. The sponsor also makes its own assessment.
Recording adverse events
- Ask open questions at every visit and review diaries, laboratory results and records.
- Record description, onset and end dates, severity, seriousness, causality, action taken and outcome.
- Use diagnoses rather than a list of separate symptoms where possible.
- Record concomitant medicines taken to treat the event.
- Follow each event until it resolves or stabilises.
Summary
An AE is any untoward event, related or not; an ADR is suspected to be caused by the product.
SAE criteria are death, life-threatening event, hospitalisation, disability, birth defect and other medically important events.
Severity, seriousness and causality are separate assessments.
Record completely, follow to resolution and report SAEs promptly.
Check your understanding
Draft study guide. Spotted an error or something unclear? Tell us at hello@scintria.com. This is educational material, not clinical or regulatory advice.